Study Participant

Clinical research helps develop new medications for people living with a skin disease. Since 2000, Innovaderm has conducted numerous studies to advance research for different skin conditions. By choosing to participate* in one of our studies, you help discover new therapies and support people with skin conditions worldwide.

*You may receive financial compensation for your time and travel expenses related to your participation in a study.

A Participant’s Journey

www

Phone or online evaluation

We need some information to see if you can join a study.This can be done over the phone or online. If you qualify, you will get an appointment for an in-person evaluation at our clinic.

In-person evaluation

At the clinic, our medical staff will perform a physical examination to check if you can join the study. If you qualify, you will get your first study appointment. If not, we may refer you to another study.

During the study

Follow the instructions from our team and attend all appointments. Our health professionals will monitor you closely. If you have any questions or concerns, our team is here to help.

After the study

Congratulations on completing the study! Feel free to share your experience with our team, family and friends, or colleagues. If you are interested in joining another study, contact our team or visit our website.

“I feel confident. The safety and health of the subject is essential and paramount. I am completely satisfied.”
Research participant since 2010
“My boundaries are their boundaries. There is no obligation, and they respect my limitations. We have free will and we feel like we're making a difference.””
Research participant since 2021
“I have been participating in clinical studies for 20 years. I come here for my health; the frequent medical follow-ups make me feel secure. We are taken care of, the people are very courteous, and we are always well treated.”
Research participant since 2001

Testimonials provided by trial participants are personal experiences and do not necessarily represent the views of the trial sponsor. They are not a substitute for medical advice, and the results of the trial may vary based on individual circumstances. Always consult with your healthcare provider before making any medical decisions.

Participate In Dermatology Clinical Studies

When you join a study, your study center will tell you how many visits are needed. This can range from a few days to several months, depending on the study. You may receive financial compensation based on the number of visits. 

Available Studies - QC, Montréal


Study Name Compensation Duration
Eczema – J-AD01 Up to $2,280 17 visits over 37 weeks
Alopecia Areata - A-AA05 Up to $2,260  12 visits over 28 weeks
Acne Vulgaris - P-HV01 Up to $3,050 32 visits over 12 weeks
Healthy Volunteers - P-HV01 Up to $2,925 19 visits over 10 weeks
Plaque Psoriasis – A-PP04 Up to $1,650 11 visits over 28 weeks
Nonsegmental Vitiligo – P-V01 Up to $1,530 18 visits over 24 months
Eczema – A-AD06 Up to $4,395 22 visits over 24 months
Chronic Hand Eczema - I-HE01 Up to $1,200 10 visits over 40 weeks
Discoid Lupus Erythematosus - I-DL01 Up to $525 4 visits over 32 weeks
Chronic Hands Eczema and Healthy Volunteers - 5024 Up to $615 6 visits over 17 weeks

You are not from Montreal? No Problem!

If you are interested in participating in a clinical study but are not located in Montreal, we encourage you to explore research opportunities in your area. Many cities have research clinics conducting similar studies.

FAQs

Each study has guidelines about who can join. These guidelines (also called inclusion/exclusion criteria) help ensure reliable results and participants safety. Factors like age, gender, disease type, and medical history determine if a person can participate in a study. Some studies need participants with specific conditions, while others need healthy volunteers.

Benefits

Clinical studies are designed and executed to allow eligible subjects to:

  • Play an active role in their own health care.
  • Gain access to new research treatments before they are widely available.
  • Obtain expert medical care at health care facilities during the study.
  • Help others by contributing to medical research.

    Risks

There are risks to clinical studies, including:

  • There may be unpleasant, serious or even life-threatening side effects to the experimental treatment.
  • The experimental treatment may not be effective for the subject.
  • The protocol may require more of their time and attention than would a non-protocol treatment, including trips to the study site, more treatments or hospital stay

People should know as much as possible about the clinical study and feel comfortable asking the members of the healthcare team questions about it and the care expected while in a study. The following questions might be helpful for the subject to discuss with the healthcare team. Some of the answers to these questions are found in the informed consent document.

  • What is the purpose of the study?
  • Why do researchers believe the experimental treatment being tested may be effective?
  • Has it been tested before? What kinds of tests and experimental treatments are involved?
  • How do the possible risks, side effects, and benefits in the study compare with my current treatment?
  • How might this study affect my daily life?
  • How long will the study last?
  • How long will the visits last?
  • Who will pay for the experimental treatment?
  • Will I be reimbursed for other expenses?
  • What type of long-term follow-up care is part of this study?
  • How will I know that the experimental treatment is working?
  • Will results of the studies be provided to me?
  • Who will be in charge of my care?

Clinical studies follow ethical and legal codes to protect participants. Most studies are federally regulated with safeguards in place. Researchers follow detailed study plan and report results to government agencies and ethics boards.


Participants’ personal information, including names and contact information, are kept confidential and secure and are not disclosed to any 3rd parties without participant’s consent, unless required by law.


Innovaderm has a Confidentiality Officer who is responsible for ensuring that personal information are collected, used, disclosed (shared) and retained in compliance with applicable privacy regulations. For more information, visit our privacy policy page.

Before joining a study, you will receive a document with all the study details, including its purpose, duration, procedures, risks, and benefits. You can decide whether to sign this informed consent form (ICF). The ICF is not a contract and you can withdraw from the study at any time.

Side effects are any undesired actions or effects of the experimental drug or treatment. Negative or adverse effects may include headache, nausea, skin irritation, or other physical or mental problems. Experimental treatments must be evaluated for both immediate and long-term side effects.

Some studies evaluate the safety and tolerance of treatments, while others assess effectiveness. Information on effectiveness is included in the informed consent form.

Participants may receive financial compensation for travel expenses and time spent in the study after the pre-screening phase. This compensation is usually sent by mail a few weeks after the end of the study, when the visits are completed. Please note that there is no compensation for the pre-screening phase.

You can leave the study at any time without penalty. Inform the research team if you decide to withdraw. You will be compensated for completed visits and may be contacted for long-term monitoring.

Studies involving research products must be approved by Health Canada and an ethics committee. These bodies ensure the study is safe and ethical. Any changes to the study must also be approved. Researchers report new information to these agencies to maintain study approval and participant safety.

Be the First to Know About New Studies!

Share your details and the condition you are interested in, and we will notify you when a relevant study becomes available.

Contact Us

514-521-3111

Monday – Friday 9 am to 7 pm

3530 Saint-Laurent boulevard, Suite 400, Montreal, QC, H2X 2V1, Canada

Newsletter subscription resources